Endpoints News 生物医药· ENDPOINTS·· 28 天前AI 评分26
Arbutus乙肝药物暂停审批解除、药品立项及Ultomiris加速获批
A hepatitis B hold lifted and drug tabled; Ultomiris' accelerated approval
AI 导读
Arbutus公司研发的乙肝药物被解除暂停审批状态,同时该药正式立项。Ultomiris获得加速批准。此外,文章还提及Biohaven、Arcus Sciences以及Boehringer Ingelheim与Microsoft的跨界合作动态。
正文
Plus news about Biohaven, Arcus Biosciences and a Boehringer Ingelheim and Microsoft collaboration.
Hold on Arbutus drug lifted: It’s been a long, tough road for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news